Our Mastery
Testimonial
- "Amazing success ratio in such uncertain market and paid service is very affordable ...Good job done by your team...keep it up guys."
-Venkat (Chennai)
Party Plot Owner - "I am trading in stock market since last 8 years; I have subscribed services from many advisory companies. Conclusion is that no one can provide 100% accuracy in this NSE market. But accuracy of intraday tips from this firm is the highest among all share tips companies" Rahul Varma (Mumbai)
Owner of an Insurance Firm - "I have taken free trial of intraday tips for 2 days and 80% call is profitable. Then I have subscribed paid membership for trading advice and now I am quite satisfied with services. Important thing is do not think more; Just trade what you are suggested" -Kevin Patel (Ahmedabad)
BDM at IT Company - "Made Good Profit in the Intraday, Jackpot Calls, F&o Tips. Overall Service is very good. Especially I like your Fast tips Sms Service & Exit Call System. Your tips have very good performance." -Manoj Arora (Delhi)
CEO of Real Estate Company
Granules India Ltd share price today (on 4 October 2023).
We Provide Best stock tips for Granules India Ltd. A1 Intraday Tips is accurate share tips Provider Company in India in Nse market. A1 Intraday Tips, also provide Daily Charts with Nse Share Market current price of Granules India Ltd with today performance in nse market. Contact Us for Jackpot Stock tips.
Get Free Stock Tips for Granules India Ltd
BSE: 532482 | NSE: GRANULES | ISIN: INE101D01012 Market Cap: [Rs.Cr.] 435 | Face Value: [Rs.] 10 Industry: Pharmaceuticals - Indian - Bulk Drugs
Incorporated as a private limited company in 1991, Granules India (GIL) was converted into a public limited company in Feb.'93. It commenced its operations in Apr.'91 as a merchant exporter of bulk drugs like paracetamol, guaifenesin and chloro pheniramine maleate. The company exports to the US, Europe, Mexico and Hongkong. Since 1992, GIL concentrated on export of paracetamol powder. In Aug.'94, GIL took over Triton Laboratories (TL), a group company from which GIL was procuring the drugs for exports. GIL also acquired a sick unit which was manufacturing bulk drugs, from the Andhra Pradesh State Financial Corporation (APSFC) in Mar.'94. GIL implemented the ongoing project taken over from TL to manufacture bulk drugs like folic acid, salbutamol sulphate, brom pheniramine maleate and direct compression (DC) blends of paracetamol, through the process of granulation. The unit, an EOU, is located at Hyderabad, Andhra Pradesh. Commercial production of folic acid commenced in Aug.'95.
It came out with a public issue in Sep.'95 to part-finance this project. Company has completed expansion of Guaifenesin capacity from 100 Mts to 240 Mts per annum. Company had developing new products like Brom Pheniramine Maleate & Chloro Pheniramine Maleate, & is in process of developing new bulk drug for the export market. Company is very much hopeful about company's performance due to expansion of project will be completed in the current year. The Company set up a 100% marketing subsidiary in US to enhance its exposure in the large pharmaceutical market in the world. The Gagillapur plant commences its commercial production of Line II(installed capacity 3200 MT) which was commenced its July,2003 and the remaining 4000 MTPA is expected to go on stream in the first half of 2003-04. The total project cost is Rs. 30 crore.
According to the Consolidated - Audited financial statement for the Year of 2012, total net operating revenues increased with 37.68%, from INR 475.98 tens of millions to INR 655.34 tens of millions. Operating result increased from INR 57.61 tens of millions to INR 79.76 tens of millions which means 38.45% change. The results of the period increased 43.30% reaching INR 29.95 tens of millions at the end of the period against INR 20.9 tens of millions last year. Return on equity (Net income/Total equity) went from 9.51% to 12.22%, the Return On Asset (Net income / Total Asset) went from 5.55% to 8.37% and the Net Profit Margin (Net Income/Net Sales) went from 4.39% to 4.57% when compared to the same period of last year. The Debt to Equity Ratio (Total Liabilities/Equity) was 35.93% compared to 171.48% of last year. Finally, the Current Ratio (Current Assets/Current Liabilities) went from 3.22 to 1.22 when compared to the previous year.
Under one plan with Unbelievable lowest price
( Equity cash, Nse f&o tips, jackpot tips, sure shot call, btst/stbt call/nifty tips/bank nifty tips)
free trial available for 2 days
| GITANJALI | GLENMARK | GMBREW | GOACARBON |
| GODREJPROP | GOLDIAM | GKB | GLOBOFFS |
| GKWLIMITED | GLOBUSSPR | GMRINFRA | GODREJCP |
| GMDCLTD | GODFRYPHLP | GOKEX | GOKUL |
| GLAXO | GLODYNE | GNFC | GODREJIND |
| GOLDENTOBC | GPIL | GRASIM | GRUH |
| GTL | GUJFLUORO | GVKPIL | GPPL |
| GRAVITA | GSFC | GTOFFSHORE | GUJNRECOKE |
| GRANULES | GREENPLY | GSKCONS | GUJALKALI |
| GUJRATGAS | GRAPHITE | GRINDWELL | GSPL |
| GUJAPOLLO | GULFOILCOR |
to Earn daily Rupees 10000 to 15000
Our all call under in one plan
(equity, fno, jackpot,sure shot, nifty, bank nifty tips )
Nse Listed Companies with Live Charts
with live charts starting with that Alphabet.)
| A | B | C | D | E | F | G | H | I | J |
| K | L | M | N | O | P | Q | R | S | T |
| U | V | W | X | Y | Z |
